CD BioGlyco Expands Glycobiology Research Capabilities with Custom Glycoconjugate Synthesis Service
CD BioGlyco's new custom glycoconjugate synthesis service enables researchers to study glycan functions in cell recognition and immune responses, advancing biomedical research capabilities.
CD BioGlyco has expanded its service offerings with custom glycoconjugate synthesis, providing research teams with specialized carbohydrate-based molecules essential for laboratory and biomedical experiments. The service utilizes the Glyco™ Synthesis Platform to connect glycans—either client-supplied or produced in-house—to proteins, lipids, or other carrier molecules, with each batch undergoing rigorous review to confirm structure and uniformity.
The custom glycoconjugate synthesis process involves linking various glycans, including mono-, oligo-, or polysaccharides, to proteins, lipids, or other molecules through a combination of chemical techniques and enzyme-driven steps. Chemical approaches typically rely on activation and coupling methods, while enzyme-based methods employ glycosyltransferases or similar enzymes. Researchers can request specific modifications or labels on saccharides, proteins, or lipids tailored to their experimental requirements.
These synthesized glycoconjugates enable scientists to study how glycans influence critical biological processes such as cell recognition, signaling pathways, and immune responses. They serve as valuable reagents for preparing research materials and investigating molecular interactions involving glycans, often making experiments feasible that would be challenging with unmodified molecules. The service has become an integral component of modern research workflows, particularly in addressing novel or unexpected research questions.
According to Anna, a company spokesperson, "This service has slowly become a regular part of what we do in research. We check each batch several times to make sure it works as intended—and sometimes a few small adjustments are necessary. We really enjoy collaborating with academic teams, especially when it helps tackle new or unexpected research questions." Detailed information about the system and its research applications is available at https://www.bioglyco.com/custom-glycoconjugate-synthesis.html.
As a sub-brand of CD Bio Group, CD BioGlyco offers comprehensive glycobiology-related products, analysis, custom synthesis, and design services to advance global glycobiology research. The expansion into custom glycoconjugate synthesis represents a significant enhancement to the tools available for studying complex biological systems and developing new therapeutic approaches.